首页 | 官方网站   微博 | 高级检索  
     

基于网络药理学和细胞生物学研究黄芪治疗糖尿病肾病的作用机制
引用本文:田崇梅,傅利萍,夏道宗.基于网络药理学和细胞生物学研究黄芪治疗糖尿病肾病的作用机制[J].中国药学杂志,2022,57(1):52-61.
作者姓名:田崇梅  傅利萍  夏道宗
作者单位:1.浙江中医药大学附属绍兴中医院, 浙江 绍兴 312000;
2.浙江中医药大学, 杭州 310053
基金项目:国家自然科学基金项目资助(81673656);浙江省自然科学基金项目资助(LGF20H300003);浙江省医药卫生厅项目资助(2019RC085);绍兴市科技局医卫类项目资助(2018C30115)。
摘    要:目的 运用网络药理学和细胞生物学验证探讨黄芪治疗糖尿病肾病的分子作用机制.方法 通过中药系统药理学数据库(TCMSP)筛选出黄芪有效成分;利用Drugbank数据库、GeneCards和OMIM数据库筛选黄芪有效成分和糖尿病肾病的相关靶点;应用String数据库绘制PPI网络;通过Cytoscape软件绘制黄芪-成分-...

关 键 词:黄芪  糖尿病肾病  网络药理学  MAPK信号通路
收稿时间:2021-05-13

Exploration into the Mechanism of Effective Components and Potential Targets of Astragali Radix in Treatment of Diabetic Nephropathy Based on Network Pharmacology and Cell Biology Verification
TIAN Chong-mei,FU Li-ping,XIA Dao-zong.Exploration into the Mechanism of Effective Components and Potential Targets of Astragali Radix in Treatment of Diabetic Nephropathy Based on Network Pharmacology and Cell Biology Verification[J].Chinese Pharmaceutical Journal,2022,57(1):52-61.
Authors:TIAN Chong-mei  FU Li-ping  XIA Dao-zong
Affiliation:1. Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing 312000, China;
2. College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
Abstract:OBJECTIVE To explore the molecular mechanism of Astragali Radix in the treatment of diabetic nephropathy(DN) by the network pharmacology and cell biology verification. METHODS The main active ingredients of Astragali Radix were obtained through TCMSP. Drugbank, Gene Cards and OMIM were used to predict and screen the targets of Astragali Radix and DN. The PPI network was constructed using the String database. The GO and KEGG pathways involved in the targets were analyzed by DAVID. The ingredients-targets-diseases network was constructed by Cytoscape software. Cell biology verification analyzes the protective effect of active ingredients in Astragali Radix on DN. RESULTS The results showed that 12 active components and 56 targets of Astragali Radix were involved. The network results showed that the process of oxidative stress, inflammation, apoptosis were mainly involved, which played a role in the treatment of DN by adjusting the MAPK, HIF, ErbB, p53, NF-κB and other signal pathways. Its mechanism of action involved antioxidation, anti-inflammatory and anti-apoptosis. Cell biology verification analysis showed that quercetin and kaempferol could reduce cell apoptosis caused by high glucose, reduce ROS level(P<0.05), and improve CAT and SOD capacity(P<0.05). Quercetin could significantly reduce the protein expression levels of phosphorylated P38 MAPK and JNK in HK-2 cells caused by high glucose(P<0.01). CONCLUSION In the current study, the mechanism of Astragali Radix in the treatment of DN by network pharmacology was explored. Results showed that Astragali Radix could act on multi-ingredient, multi-target and multi-pathway played a potential therapeutic role on DN. The prediction results of network pharmacology suggest that the quercetin and kaempferol in Astragali Radix might be the material basis for treatment of DN. The analysis proved the quercetin and kaempferol in Astragali Radix can reduce cell damage caused by high glucose, reduce oxidative stress, and improve antioxidant capacity by in vitro experiment, providing a new idea for Astragali Radix in the treatment of DN.
Keywords:Astragali Radix  diabetic nephropathy  network pharmacology  MAPK signal pathway
本文献已被 维普 等数据库收录!
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号